Literature DB >> 10406144

Follow-up study of human corneal endothelial cells, photographed in vivo before enucleation and 20 years later in grafts.

K Vasara1, K Setälä, P Ruusuvaara.   

Abstract

PURPOSE: To evaluate the long-term (20-year) survival of transplanted human corneal endothelial cells.
METHODS: The donor endothelium had been photographed 20 years ago with a specular microscope both before enucleation in the melanomatous eye and in situ after keratoplasty. The same donor endothelial cells were now photographed again 20 years later with a modern specular microscope to ascertain the morphology and cell density of the grafts.
RESULTS: In the earlier study the mean postoperative endothelial cell density was 1357+/-543 cells/mm2, the average cell loss 11 months postoperatively being 48.2%; 20.5 years postoperatively the cell loss was 62.9% of the preoperative cell count. In our well-documented patient population the endothelial cell loss during the last 19 years had been only 14.7%, which amounts to a cell loss of less than 1% per year.
CONCLUSION: In transplanted corneas, the main endothelial cell loss seems to take place during the first 1-2 postoperative years.

Entities:  

Mesh:

Year:  1999        PMID: 10406144     DOI: 10.1034/j.1600-0420.1999.770305.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  2 in total

1.  Anti-apoptotic gene therapy prolongs survival of corneal endothelial cells during storage.

Authors:  T A Fuchsluger; U Jurkunas; A Kazlauskas; R Dana
Journal:  Gene Ther       Date:  2011-03-17       Impact factor: 5.250

2.  Corneal endothelial cells are protected from apoptosis by gene therapy.

Authors:  Thomas A Fuchsluger; Ula Jurkunas; Andrius Kazlauskas; Reza Dana
Journal:  Hum Gene Ther       Date:  2011-03-17       Impact factor: 5.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.